First Foundation Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$191K 462
2023
Q4
$191K Sell
1,000
-82
-8% -$15.5K 0.01% 341
2023
Q3
$215K Sell
1,082
-52
-5% -$12.3K 0.01% 381
2023
Q2
$324K Buy
1,134
+30
+3% +$8.33K 0.01% 303
2023
Q1
$239K Sell
1,104
-8
-0.7% -$1.56K 0.01% 335
2022
Q4
$229K Sell
1,112
-64
-5% -$16.2K 0.01% 348
2022
Q3
$327K Buy
1,176
+12
+1% +$3.05K 0.02% 280
2022
Q2
$223K Buy
+1,164
New +$205K 0.01% 361

Other funds holding SWAV

First Foundation Advisors's SWAV Position: Q1 2024 in Review

First Foundation Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2024, closing a stake of 1,000 shares — an estimated $191K sold.

First Foundation Advisors first reported a position in SWAV in Q2 2022 and held it in 7 quarters. The position peaked at $327K in Q3 2022. 488 funds tracked by Wall St. Rank hold SWAV as of Q1 2024.

  • First Foundation Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • First Foundation Advisors sold 1,000 Shockwave Medical, Inc. Common Stock shares in Q1 2024, an estimated $191K.
  • First Foundation Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • First Foundation Advisors's Shockwave Medical, Inc. Common Stock position peaked at $327K in Q3 2022.
  • 488 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2024.

Based on First Foundation Advisors's 13F filing for Q1 2024, filed 10 May 2024.